Cindy Tahl, General Counsel and Secretary at FATE THERAPEUTICS INC (FATE), sold 48,726 shares at $2.40 ($117K) on 2023-11-09, disclosed to the SEC on 2023-11-13.
Scheduled sale ($117k) by General Counsel and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.40 | 24,363 | $58K | 50.0% |
| 2 | $2.40 | 24,363 | $58K | 50.0% |
| Total | $2.40 avg | 48,726 | $117K | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $11K | — | Filing → |
| FATE | SELL | 2025-08-05 | $10K | — | Filing → |
| FATE | SELL | 2025-01-13 | $9K | — | Filing → |